Treatment of Rhabdomyolysis
Aggressive intravenous fluid resuscitation is the cornerstone of treatment for rhabdomyolysis, with a goal urine output of 300 mL/hour to prevent acute kidney injury. 1, 2
Diagnosis and Assessment
- Rhabdomyolysis is characterized by the breakdown of skeletal muscle with release of intracellular contents into circulation, often presenting with muscle pain, weakness, and dark urine 3
- Laboratory diagnosis requires creatine kinase (CK) levels at least 10 times the upper limit of normal and assessment of myoglobinuria 4
- Comprehensive laboratory workup should include:
Treatment Algorithm
Immediate Management
- Begin immediate, aggressive intravenous fluid resuscitation:
Fluid Management
- Use isotonic crystalloid solutions (normal saline) for initial resuscitation 3
- Early initiation of fluid resuscitation is critical, as delayed treatment increases risk of acute kidney injury 1
- Continue IV fluids until CK levels decrease to less than 1,000 U/L 4
Electrolyte Management
- Monitor and correct significant electrolyte abnormalities, particularly hyperkalemia which can lead to cardiac arrhythmias 1, 2
- Obtain serial ECGs to evaluate for cardiac complications of hyperkalemia 5
- Address hypocalcemia if symptomatic 3
Compartment Syndrome Management
- Monitor for compartment syndrome, a serious complication of rhabdomyolysis 1
- Early signs include pain, tension, paresthesia, and paresis; late signs include pulselessness and pallor 1
- Consider fasciotomy when:
Special Considerations
Renal Protection
- Maintain adequate hydration throughout treatment 1
- Consider sodium bicarbonate for patients who are acidotic 4
- Consider mannitol for patients whose urine output is not at goal despite adequate fluid resuscitation 4
- Renal replacement therapy may be necessary for severe cases with refractory hyperkalemia or severe acidosis 3
Medication Considerations
- Avoid medications that can exacerbate rhabdomyolysis, particularly succinylcholine 1
- Discontinue any causative medications, particularly statins if they are the suspected cause 2
- For perioperative patients, consider discontinuation of dietary supplements associated with higher risk for myositis or rhabdomyolysis 1
Prevention of Complications
- Monitor for and address complications:
Cause-Specific Management
- For exertional rhabdomyolysis: proper calibration of training and conditioning, especially during transition periods 2
- For medication-induced rhabdomyolysis: identify vulnerable patients before starting high-risk medications 2
- For infectious causes: appropriate antimicrobial therapy based on suspected pathogen 2
- For immune checkpoint inhibitor-induced myositis with rash: consider high-dose corticosteroids 2